References
"Ocular allergies." By Clifford W. Bassett, MD, FAAAAI. The American Academy of Allergy, Asthma, & Immunology. 2007. http://www.aaaai.org. Accessed July 2008.
"Allergic conjunctivitis." Uptodate.com. Last updated February 2008. http://www.uptodate.com. Accessed July 2008.
"Tips for administering eye drops." The American Academy of Allergy, Asthma, & Immunology. http://www.aaaai.org. Accessed July 2008.
"Vernal Keratoconjunctivitis (VCK)." The University of Michigan Kellogg Eye Center. 2008. http://www.kellogg.umich.edu. Accessed July 2008.
"Atopic Keratoconjunctivitis." The University of Michigan Kellogg Eye Center. 2008. http://www.kellogg.umich.edu. Accessed July 2008.
"Why are allergies becoming more common?" by Daniel More, MD. Updated November 20, 2007. http://allergies.about.com. Accessed October 2008.
Akpek EK. Ocular Allergy. Available at: http://www.uveitis.org. Accessed December 17, 2002.
American Academy of Allergy, Asthma, and Immunology. Eye Allergies: Believe your eyes, and see what they may be telling you. Available at: http://allergy.mcg.edu. Accessed December 17, 2002.
American Academy of Allergy, Asthma, and Immunology. Ocular Allergies, February 2001. Available at: http://www.aaaai.org. Accessed December 17, 2002.
Bielory L. Update on ocular allergy treatment. Expert Opinion on Pharmacotherapy 2002;3(5):541-553.
Gross RD. Ocular allergy signs, symptoms best handled after specifics answered. Ophthalmology Times May 1, 2002.
Schmid KI, Schmid LM. Ocular allergy: causes and therapeutic options. Clin Exp Optom 2000;83:5:257-270.
Abelson MB, Udell IJ. H2 receptors in the human ocular surface. Arch Ophthalmol 1981;99:302-304.
Abelson MB, Chambers WA, Smith LM. Conjunctival allergen challenge: a clinical approach to studying allergic conjunctivitis. Arch Ophthalmol 1990;108:84-88.
Abelson MB, Chapin MJ, Current and Future Topical Treatments for Ocular Allergy. Comp Ophthalmol Update 1:2000, 303-320.
Spangler DL, Abelson MB, Ober A, Gomes PJ. Randomized, Double-Masked Comparison of Olopatadine Ophthalmic Solution, Mometasone Furoate monohydrate Nasal Spray, and Fexofenadine Hydrochloride Tablets Using the Conjunctival and Nasal Allergen Challenge Models. Clinical Therapeutics 25(8); 2003, 2245-2267
Abelson MB, Pratt S, Mussoline JF, Townsend D. One-Visit, Randomized, Placebo-Controlled, Conjunctival Allergen Challenge Study of Scanning and Imaging Technology for Objective Quantification of Eyelid Swelling in the Allergic Reaction with Contralateral Use of Olopatadine and Artificial Tears. Clinical Therapeutics 25(7); 2003, 2070-2084.
Abelson MB, Smith L, Chapin M. Ocular Allergic Disease: Mechanisms, Disease Sub-types, Treatment. The Ocular Surface 1(3); July 2003, 127-149.
| |
|
View References for this Health Topic
|
Create Date: 1/2/03
Date Last Updated: 10/7/08
Review Date: 10/1/08
|
|